Passaro A, Russo GL, Passiglia F, D'Arcangelo M, et al. Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP). Lung Cancer 2022;174:118-124.
PMID: 36379124